Tate & Lyle (TATE) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
2 Mar, 2026Executive summary
Third quarter trading and operating performance were in line with expectations and consistent with the first half, with full-year guidance unchanged.
Strategic focus remains on returning to top line growth through selective investments, portfolio expansion, and targeted capability and technology investments.
Integration of CP Kelco is progressing well, supporting cross-selling, revenue, and cost synergies.
Customer engagement is high, especially in innovation and fiber fortification trends.
Customer framework agreement renewals for 2026 are well-advanced, with selective investments to drive volume and revenue growth.
Financial highlights / Financial performance and trading update
On a pro forma, constant currency basis, Q3 revenue was 2% lower year-over-year due to muted market demand; regional performance was broadly stable.
Reported revenue, including CP Kelco, was 15% higher.
For the nine months to December 31, 2023 (or 2025): Americas revenue down 2%, EMEA down 5%, Asia Pacific up 1% on a pro forma basis.
Modestly higher pricing in the Americas was offset by lower volume; EMEA saw lower pricing, while Asia Pacific growth was volume-driven.
Outlook and guidance
Full-year guidance remains unchanged; no assumed improvement in market outlook for Q4.
Full-year outlook for 2026 remains unchanged, expecting low single-digit declines in revenue and EBITDA in constant currency versus prior year.
More detailed guidance for FY27 will be provided with full-year results in May.
Selective price investments are being made to drive volume and revenue growth, with a slightly higher scale than last year.
Continued focus on actions to improve top-line performance and leverage portfolio strengths in sweetening, mouthfeel, and fortification.
Latest events from Tate & Lyle
- $1.8B deal creates a global specialty food leader with strong synergies and growth prospects.TATE
Business Combination (Q&A)3 Feb 2026 - A $1.8B deal creates a global specialty food leader, targeting strong cost and revenue synergies.TATE
Business Combination3 Feb 2026 - EBITDA up 6% and margin expands as specialty strategy advances with CP Kelco and Primient sale.TATE
H1 202516 Jan 2026 - EBITDA up 6%, cash flow strong, and strategic transformation completed.TATE
H1 2025 (Q&A)16 Jan 2026 - Volume and EBITDA growth, CP Kelco integration, and strong cash generation support future synergies.TATE
Trading Update17 Dec 2025 - H1 revenue and EBITDA to decline as integration synergies are offset by softer demand.TATE
H1 2026 TU17 Dec 2025 - Transformed into a high-margin specialty leader, targeting accelerated growth and innovation.TATE
CMD 202521 Nov 2025 - Specialty focus and CP Kelco integration drive EBITDA and cash flow growth amid tariff risks.TATE
H2 202519 Nov 2025 - Revenue and EBITDA declined 3% and 6%, but CP Kelco synergies and growth actions advance.TATE
H1 202613 Nov 2025